Related Experiment Video
Updated: May 1, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Design of Carbon Nanotube Inhibitors for Main Proteinase of SARS-CoV-2: A Combined Deep Learning and Molecular
Yunju Zhang1,2, Zechen Wang1, Yanmei Yang3
1School of Physics, Shandong University, Jinan 250100, China.
Abstract:
The rapid development of machine learning (ML) and deep learning (DL) methods provides new opportunities for innovative drug discovery. While these techniques are widely used in docking organic molecules (drugs) with protein, an evaluation of the performance of ML and DL in treating nanostructures remains lacking. This situation becomes the main hindrance for the development of nanostructure-based medicine and medical materials. In this study, we have compared the performance of a recently developed DL model, named DeepRMSD + Vina, with the traditional molecular dynamic (MD) simulations in treating the docking problem of a carbon nanotube, the most representative nanomaterial, and the main proteinase (Mpro) of SARS-CoV-2 as the representative case. Our results indicate that most of the DL-generated structures are in good agreement with the structures optimized by MD. However, minor discrepancies were indeed observed where structural alterations happened for the flexible loops near the binding pocket of Mpro, which were not addressed in the DL-generated structures. Further analyses demonstrated that the DL-generated binding pose is a metastable conformation at a local minimum on the energy surface. The transition from such a local minimum structure to a global minimum structure has to overcome an energy barrier that is accompanied by a flip of the flexible loops. In brief, we demonstrate that the DL method has considerably high efficacy in treating nanobiosystems, with potential implications for the design of nanomedicine materials. This study also shed new light on the future development direction of the DL method for enhanced docking accuracy.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025